MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Income Overview

Net Income
-$19,937,618
EPS
-$17.62
Unit: Dollar
Income Statement
2026-06-30
2025-06-30
Tax benefit
-
0
Administration expenses
670,607
57,027,850
Compensation and related taxes
2,275,937
-
Professional and consulting expenses
14,572,616
-
Occupancy expenses - related party
40,932
26,560
Research and development
625,477
223,721
Total operating expenses
18,185,569
57,278,131
Loss from operations
-18,185,569
-57,278,131
Interest expense
430,539
563,757
Interest income
161
9
Derivative expense
-
333,596
Change in fair value of derivative liabilities
13,709
212,450
Change in fair value of warrant liability
99,695
-
Other expense
-6,000
-
Settlement expense
320,000
-
Gain (loss) on extinguishment of debt, net
133,071
-871,032
Foreign currency transaction gain (loss)
32,152
-89,243
Total other income (expense), net
-677,141
-1,645,169
Loss before taxes
-18,862,710
-58,923,300
Net loss
-18,862,710
-58,923,300
Deemed dividend
932,246
0
Net loss available to common stockholders
-19,794,956
-58,923,300
Unrealized foreign currency translation gain (loss)
-142,662
49,336
Total other comprehensive income (loss)
-142,662
49,336
Total comprehensive loss
-19,937,618
-58,873,964
Basic EPS
-17.62
-14.85
Diluted EPS
-17.62
-14.85
Basic Average Shares
1,123,709
3,968,176
Diluted Average Shares
1,123,709
3,968,176
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

PPCB Income Statement Sankey DiagramSankey diagram visualizing PPCB income statement for the periodTotal comprehensiveloss-$19,937,618 (66.14%↑ Y/Y)Net loss availableto common...-$19,794,956 (66.41%↑ Y/Y)Total othercomprehensive income (loss)-$142,662 (-389.16%↓ Y/Y)Net loss-$18,862,710 (67.99%↑ Y/Y)Deemed dividend$932,246 Unrealized foreigncurrency translation...-$142,662 (-389.16%↓ Y/Y)Loss before taxes-$18,862,710 (67.99%↑ Y/Y)Loss from operations-$18,185,569 (68.25%↑ Y/Y)Total other income(expense), net-$677,141 (58.84%↑ Y/Y)Gain (loss) onextinguishment of debt, net$133,071 (115.28%↑ Y/Y)Foreign currencytransaction gain (loss)$32,152 (136.03%↑ Y/Y)Change in fair value ofderivative liabilities$13,709 (-93.55%↓ Y/Y)Interest income$161 (1688.89%↑ Y/Y)Total operatingexpenses$18,185,569 (-68.25%↓ Y/Y)Interest expense$430,539 (-23.63%↓ Y/Y)Settlement expense$320,000 Change in fair value ofwarrant liability$99,695 Other expense-$6,000 Professional and consultingexpenses$14,572,616 Compensation and relatedtaxes$2,275,937 Administration expenses$670,607 (-98.82%↓ Y/Y)Research and development$625,477 (179.58%↑ Y/Y)Occupancy expenses -related party$40,932 (54.11%↑ Y/Y)

Propanc Biopharma, Inc. (PPCB)

Propanc Biopharma, Inc. (PPCB)